Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MSC | hg19_v2_chr8_-_72756667_72756736 | -0.52 | 2.3e-03 | Click! |
TFAP4 | hg19_v2_chr16_-_4323015_4323076 | -0.14 | 4.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_152590946 Show fit | 13.64 |
ENST00000172853.10
|
nebulin |
|
chr1_+_167063282 Show fit | 13.43 |
ENST00000361200.2
|
dual specificity phosphatase 27 (putative) |
|
chr14_+_32964258 Show fit | 10.84 |
ENST00000556638.1
|
A kinase (PRKA) anchor protein 6 |
|
chr3_+_8775466 Show fit | 10.13 |
ENST00000343849.2
ENST00000397368.2 |
caveolin 3 |
|
chr2_-_175629135 Show fit | 9.77 |
ENST00000409542.1
ENST00000409219.1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
|
chr2_-_175629164 Show fit | 9.69 |
ENST00000409323.1
ENST00000261007.5 ENST00000348749.5 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
|
chr16_+_30383613 Show fit | 9.59 |
ENST00000568749.1
|
myosin light chain, phosphorylatable, fast skeletal muscle |
|
chr4_-_177190364 Show fit | 8.88 |
ENST00000296525.3
|
ankyrin repeat and SOCS box containing 5 |
|
chr17_+_65040678 Show fit | 7.97 |
ENST00000226021.3
|
calcium channel, voltage-dependent, gamma subunit 1 |
|
chr2_+_27505260 Show fit | 7.50 |
ENST00000380075.2
ENST00000296098.4 |
tripartite motif containing 54 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 22.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 20.7 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.9 | 18.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
3.5 | 17.4 | GO:0007525 | somatic muscle development(GO:0007525) |
2.0 | 16.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
2.0 | 15.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.2 | 15.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 15.2 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.2 | 14.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 11.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 59.7 | GO:0031674 | I band(GO:0031674) |
1.0 | 27.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 25.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.1 | 19.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 15.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 15.0 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 14.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 14.6 | GO:0030017 | sarcomere(GO:0030017) |
0.3 | 14.2 | GO:0031430 | M band(GO:0031430) |
0.3 | 14.0 | GO:0043034 | costamere(GO:0043034) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 63.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.1 | 27.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.8 | 16.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.9 | 14.7 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.2 | 13.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 11.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 11.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 10.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.1 | 10.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 10.1 | GO:0071253 | connexin binding(GO:0071253) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 16.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 13.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 11.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 9.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 5.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 4.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 4.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 4.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 3.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 45.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.5 | 27.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 21.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 12.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 7.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 6.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 6.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 6.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 6.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 4.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |